Key References
The content of this web site has been authored by
Professor Anthony Watson MD FRCS(Eng) FRCS(Ed) FRACS and Dr Rebecca
C Fitzgerald MA MD MRCP.
The following are key references for the information
provided:
- Fitzgerald, R. & Traidafilopoulos, G. Review
article: Barrett's oesophagus, dysplasia and pharmcolgic acid suppression.
Aliment Pharmacol Ther 15, 269-276 (2001).
- Haggitt, R. Barrett's esophagus, dysplasia and
adenocarcinoma. Gastroenterol Clin North Amer 20, 817-834 (1994).
- Jankowski, J.A., Harrison, R.F., Perry, I., Balkwill,
F. & Tselepis, C. Barrett's metaplasia. Lancet 356, 2079-85 (2000).
- Souza, R.F., Morales, C.P. & Spechler, S.J.
a conceptual approach to understanding the molecular mechanisms of cancer
development in Barrett's oesophagus. Aliment Pharmacol Ther 15, 1087-100
(2001).
- Sonnenberg, A., Soni, A. & Sampliner, R.E.
Medical decision analysis of endoscopic surveillance of Barrett's oesophagus
to prevent oesophageal adenocarcinoma. Aliment Pharmacol Ther 16, 41-50
(2002).
- Spechler, S., available., a. & process], P.P.-i.
Barrett's Esophagus. N Engl J Med 346, 836-42 (2002).
- Tytgat, G. Does endoscopic surveillance in esophageal
columnar metaplasia have any real value? Endoscopy 27, 19-26 (1995).
- Romero, Y. & Locke, G.R., 3rd. Is there a GERD
gene? Am J Gastroenterol 94, 1127-9 (1999).
- Jones, R. Gastro-oesophageal reflux disease in
General Practice. Scand J Gastroenterol 30, 35-38 (1995).
- Watson, A. & Caygill, C. Changing incidence
of columnar-lined (Barrett's) oesophagus in the UK. Gastroenterology
116, A351 (1999).
- Watson, A. Surgical management of gastro-oesophageal
reflux disease. Br J Surg 83, 1313-5 (1996).
- Reid, B.J., Levine, D.S., Longton, G., Blount,
P.L. & Rabinovitch, P.S. Predictors of progression to cancer in
Barrett's esophagus: baseline histology and flow cytometry identify
low- and high-risk patient subsets. Am J Gastroenterol 95, 1669-76 (2000).